contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Biotage operates in the biotechnology industry and focuses on the development and manufacture of products for chemical analysis and preparative chromatography. The company's products are aimed at researchers and laboratories in drug development and food analysis. The operations are international and target companies and institutions globally. Biotage was founded in 1987 and is headquartered in Uppsala.

Biotage

A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders has been formed for Biotage AB in accordance with the principles adopted by ...

<div class="mfn-preamble"><p><strong>A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 25 April 2024. The Nomination Committee shall, before the Annual General Meeting 2025, prepare proposal for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, election of Auditors, the determination of fees and matters pertaining thereto.</strong></p></div><div class="mfn-body"><p>The members of the Nominations Committee are:</p><ul><li>Kugan Sathiyanandarajah, Chairman of the Nomination Committee, appointed by Gamma Biosciences</li><li>Patrik Jönsson, appointed by SEB Investment Management</li><li>Kristian Åkesson, appointed by Didner &amp; Gerge</li></ul><p>Kieran Murphy, Chairman of the Board of Biotage AB, is an acting member of the Nomination Committee.</p><p>Shareholders wishing to submit a proposal to the Nomination Committee may do so by sending e-mail to the Chairman of the Board of Directors of Biotage AB at:&nbsp;<a rel="noopener" href="mailto:info@biotage.com">info@biotage.com</a>. Proposals should, in order to be timely assessed by the Nomination Committee, be submitted no later than seven weeks in advance of the meeting.</p><p>The Annual General Meeting 2025 in Biotage will be held on Thursday, April 24, 2025 at 11:00am CET in Uppsala. Shareholders who want to have a matter addressed at the Annual General Meeting 2025 must submit such a proposal to the same address as above (subject “Annual General Meeting 2025” for the e-mail and the letter, respectively) seven weeks in advance of the meeting at the latest</p></div><div class="mfn-footer mfn-e7343beb9afa"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Frederic Vanderhaegen, President &amp; CEO <br>Tel: +41 797600543, <a rel="noopener" href="mailto:torben.jorgensen@biotage.com">frederic.vanderhaegen@biotage.com</a></p></div><div class="mfn-footer mfn-about mfn-0a7046178eae"><p><strong class="mfn-heading-1">About Biotage</strong></p><hr><p>Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. </p><p>Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).<br>Website: <a rel="noopener" href="https://www.biotage.com">www.biotage.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/fccfaf0c-a1a8-4c93-93dd-e43adb9290ce/biotage-appoints-nomination-committee.pdf" class="mfn-generated mfn-primary">Biotage appoints Nomination Committee</a></p></div>

Biotage appoints Nomination Committee

Voittajan kirous

Yhdysvallat velkaantuu ja dollari heikkenee: Onko eurosta turvasatamaksi?

Pörsseissä ongitaan taas uusia huippuja, politikointi päällä Fed-valinnoissa

Euroopan talouskasvu murrosvaiheessa: Mikä vielä pidättelee Eurooppaa?

Pienyhtiöt ovat jääneet isoista jälkeen alkuvuoden nousumarkkinassa